Michael Neuberger (1953–2013)

Michael Samuel Neuberger, the brilliant molecular biologist whose work stimulated the development of therapeutic antibodies and transformed our understanding of antibody diversification, died in Cambridge, UK, on 26 October from myeloma (a cancer of antibody-producing B cells), a week before his 60th birthday. Michael was the first to recognize this irony, writing after his diagnosis, “So after 35 years of tormenting antibodies in the lab, they are now getting their own back on me in the clinic.”